bf/NASDAQ:LPTX_icon.jpeg

NASDAQ:LPTX

Leap Therapeutics, Inc.

  • Stock

USD

Last Close

0.41

06/11 22:17

Market Cap

75.00M

Beta: 0.74

Volume Today

217.02K

Avg: 600.93K

PE Ratio

−1.13

PFCF: −1.85

OverviewFinancialsAPI

    Description

    Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -6-4-222019-04-012020-05-142022-03-112023-08-142024-08-12

    Revenue (Estimate*)

    200K400K600K800K1M1.20M2019-04-012020-05-142022-03-112023-08-142024-08-12

    *Estimate based on analyst consensus